Avenue Therapeutics Inc. (NASDAQ: ATXI)
$1.9200
+0.0400 ( +1.59% ) 5.1K
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
Market Data
Open
$1.9200
Previous close
$1.8800
Volume
5.1K
Market cap
$3.96M
Day range
$1.8500 - $1.9600
52 week range
$1.6000 - $15.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| upload | Comment letters | 2 | May 08, 2024 |
| def | Proxies and info statements | 5 | May 06, 2024 |
| defa14a | Other | 3 | May 06, 2024 |
| s-3 | Registration statements | 5 | May 06, 2024 |
| sc | Insider transactions | 1 | May 02, 2024 |
| 8-k | 8K-related | 20 | May 01, 2024 |
| 8-k | 8K-related | 17 | Apr 26, 2024 |
| sc | Insider transactions | 1 | Apr 17, 2024 |
| 4 | Insider transactions | 1 | Apr 17, 2024 |
| 8-k | 8K-related | 14 | Mar 29, 2024 |